supp.fit

Sveikata

Sveikatal is developing drug candidates that can treat major diseases, including type 2 diabetes, fatty liver disease, hyperlipidemia, and cancer. Sveikatal’s discovery and IP platform is based on more than twenty years of cutting-edge research on vitamin A and its metabolites, developed at Cornell University and Weill Cornell Medical College (New York, USA). This program continues to be supported by National Institutes of Health (NIH) and other organizations. Preclinical studies have already identified promising compounds that treat four different diseases. These drug candidates may provide n

4 products in our catalogue.

sveikatalinc.com
Products
4

Products we hold for this brand, not the size of the company.

Categories
2

Distinct product categories these listings fall into.

Median price
$249.90

Half its products cost less than this, half cost more.

Explore the science behind Sveikata products

Compare all ingredients

Evidence from published research for Sveikata supplements

Goals

Benefits

Products